{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:03:18Z","timestamp":1785769398244,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.placenta.2022.02.017","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T13:00:11Z","timestamp":1645707611000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-9216","authenticated-orcid":false,"given":"S.","family":"Rowson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"De Guingand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Langston-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"da Silva Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.placenta.2022.02.017_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2022.02.017_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.placenta.2022.02.017_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.20117","article-title":"Prediction of pre-eclampsia: review of reviews","volume":"54","author":"Townsend","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2022.02.017_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.placenta.2022.02.017_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","article-title":"Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth","volume":"58","author":"Jebbink","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.placenta.2022.02.017_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00365513.2016.1190863","article-title":"Sflt-1 in heart failure: relations with disease severity and biomarkers","volume":"76","author":"Gruson","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.placenta.2022.02.017_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signalling, and has antiangiogenic activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2022.02.017_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119547","article-title":"Full-length human placental sFlt-1- e15a isoform induces distinct maternal phenotypes of preeclampsia in mice","volume":"10","author":"Szalai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2022.02.017_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110867","article-title":"In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy","volume":"9","author":"Szalai","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.placenta.2022.02.017_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.06.011","article-title":"Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period","volume":"207","author":"Petrozella","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2022.02.017_bib11","first-page":"1","article-title":"Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia","volume":"16","author":"Palmer","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2022.02.017_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7498-6_3","article-title":"Assessing the circulating placental-specific anti-angiogenic protein sFLT-1 e15a in preeclampsia","volume":"1710","author":"Palmer","year":"2018","journal-title":"Preeclampsia"},{"key":"10.1016\/j.placenta.2022.02.017_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2022.02.017_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preghy.2018.04.014","article-title":"Economic evaluation of sFlt-1\/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals","volume":"13","author":"Figueira","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2022.02.017_bib15","doi-asserted-by":"crossref","first-page":"4096847","DOI":"10.1155\/2019\/4096847","article-title":"sFlt-1\/PlGF ratio as a predictive marker in women with suspected preeclampsia: an economic evaluation from a Swiss perspective","volume":"2019","author":"Hodel","year":"2019","journal-title":"Dis. Markers"},{"issue":"87","key":"10.1016\/j.placenta.2022.02.017_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20870","article-title":"Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis","volume":"20","author":"Frampton","year":"2016","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.placenta.2022.02.017_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv. Res."},{"issue":"18","key":"10.1016\/j.placenta.2022.02.017_bib18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/14767058.2016.1242122","article-title":"Budget impact analysis of sFlt-1\/PlGF ratio as prediction test in Italian women with suspected preeclampsia","volume":"30","author":"Frusca","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2022.02.017_bib19","article-title":"Economic evaluation of the sFlt-1\/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study","author":"Ohkuchi","year":"2021","journal-title":"Hypertens. Res."},{"issue":"10183","key":"10.1016\/j.placenta.2022.02.017_bib20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"issue":"9761","key":"10.1016\/j.placenta.2022.02.017_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"Von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.placenta.2022.02.017_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.preghy.2020.10.005","article-title":"Placental growth factor measurements in the assessment of women with suspected preeclampsia: a stratified analysis of the PARROT trial","volume":"23","author":"Duhig","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.placenta.2022.02.017_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis","volume":"137","author":"Lim","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2022.02.017_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.preghy.2019.03.009","article-title":"Midpregnancy prediction of pre-eclampsia using serum biomarkers sFlt-1 and PlGF","volume":"16","author":"Black","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"10.1016\/j.placenta.2022.02.017_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.preghy.2013.04.119","article-title":"First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy","volume":"3","author":"Schneuer","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2022.02.017_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc19-0967","article-title":"Urinary and serum angiogenic markers in women with preexisting diabetes during pregnancy and their role in preeclampsia prediction","volume":"43","author":"Zen","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.placenta.2022.02.017_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12884-018-1992-x","article-title":"Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study","volume":"18","author":"MacDonald","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.placenta.2022.02.017_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2019.08.001","article-title":"Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma","volume":"86","author":"Rowson","year":"2019","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400422000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400422000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:05:37Z","timestamp":1758909937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400422000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S0143400422000625"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2022.02.017","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2022.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}